Furthermore, in view of the strong evidence of tobacco smoking as a risk factor and use of NSAIDs as a protective factor for colorectal cancer, we investigated possible interactions between Cox-2 gene polymorphisms and the smoking status and use of NSAIDs on the risk of adenoma development. This evidence concerns the gene PTGS2 and colorectal cancer.